An appraisal of carbon footprint of milk from commercial grass-based dairy farms in Ireland according to a certified life cycle assessment methodology

Purpose

Life cycle assessment (LCA) studies of carbon footprint (CF) of milk from grass-based farms are usually limited to small numbers of farms (<30) and rarely certified to international standards, e.g. British Standards Institute publicly available specification 2050 (PAS 2050). The goals of this study were to quantify CF of milk from a large sample of grass-based farms using an accredited PAS 2050 method and to assess the relationships between farm characteristics and CF of milk.

Materials and methods

Data was collected annually using on-farm surveys, milk processor records and national livestock databases for 171 grass-based Irish dairy farms with information successfully obtained electronically from 124 farms and fed into a cradle to farm-gate LCA model. Greenhouse gas (GHG) emissions were estimated with the LCA model in CO₂ equivalents (CO₂-eq) and allocated economically between dairy farm products, except exported crops. Carbon footprint of milk was estimated by expressing GHG emissions attributed to milk per kilogram of fat and protein-corrected milk (FPCM). The Carbon Trust tested the LCA model for non-conformities with PAS 2050. PAS 2050 certification was achieved when non-conformities were fixed or where the effect of all unresolved non-conformities on CF of milk was?<?±5 %.

Results and discussion

The combined effect of LCA model non-conformities with PAS 2050 on CF of milk was <1 %. Consequently, PAS 2050 accreditation was granted. The mean certified CF of milk from grass-based farms was 1.11 kg of CO₂-eq/kg of FPCM, but varied from 0.87 to 1.72 kg of CO₂-eq/kg of FPCM. Although some farm attributes had stronger relationships with CF of milk than the others, no attribute accounted for the majority of variation between farms. However, CF of milk could be reasonably predicted using N efficiency, the length of the grazing season, milk yield/cow and annual replacement rate (R ²?=?0.75). Management changes can be applied simultaneously to improve each of these traits. Thus, grass-based farmers can potentially significantly reduce CF of milk.

Conclusions

The certification of an LCA model to PAS 2050 standards for grass-based dairy farms provides a verifiable approach to quantify CF of milk at a farm or national level. The application of the certified model highlighted a wide range between the CF of milk of commercial farms. However, differences between farms’ CF of milk were explained by variation in various aspects of farm performance. This implies that improving farm efficiency can mitigate CF of milk.     

Biodegradation of the Alkaline Cellulose Degradation Products Generated during Radioactive Waste Disposal

The anoxic, alkaline hydrolysis of cellulosic materials generates a range of cellulose degradation products (CDP) including α and β forms of isosaccharinic acid (ISA) and is expected to occur in radioactive waste disposal sites receiving intermediate level radioactive wastes. The generation of ISA''s is of particular relevance to the disposal of these wastes since they are able to form complexes with radioelements such as Pu enhancing their migration. This study demonstrates that microbial communities present in near-surface anoxic sediments are able to degrade CDP including both forms of ISA via iron reduction, sulphate reduction and methanogenesis, without any prior exposure to these substrates. No significant difference (n = 6, p = 0.118) in α and β ISA degradation rates were seen under either iron reducing, sulphate reducing or methanogenic conditions, giving an overall mean degradation rate of 4.7×10⁻² hr⁻¹ (SE±2.9×10⁻³). These results suggest that a radioactive waste disposal site is likely to be colonised by organisms able to degrade CDP and associated ISA''s during the construction and operational phase of the facility.     

Sequence divergence in type III secretion gene clusters of the Burkholderia cepacia complex

The Burkholderia cepacia complex (BCC) comprises a group of bacteria associated with opportunistic infections, especially in cystic fibrosis patients. B. cenocepacia J2315, of the transmissible ET12 lineage, contains a type III secretion (TTS) gene cluster implicated in pathogenicity. PCR and hybridisation assays indicate that the TTS gene cluster is present in all members of the BCC except B. cepacia (formerly genomovar I). The TTS gene clusters of B. cenocepacia J2315 and B. multivorans are similar in organisation but have variable levels of gene identity. Nucleotide sequence data obtained for the equivalent region of the B. cepacia genome indicate the absence of TTS structural genes due to a rearrangement likely to involve more than one step.     

Breeding for Bio-ethanol Production in Lolium perenne L.: Association of Allelic Variation with High Water-Soluble Carbohydrate Content

Increasing the extractable sugar yield from perennial crops is one strategy to generate renewable fuels such as bio-ethanol. Lolium perenne L. (perennial ryegrass) can contain significant (>30% dry matter) water-soluble sugars in the form of polymeric fructan which is readily extracted, broken down and fermented to bio-ethanol. A population of L. perenne generated from four parents which differed in water-soluble carbohydrate (WSC) content was subjected to multiple rounds of selection and recombination on the basis of early spring WSC content to produce a high WSC, and a low WSC population. A control population was generated by selecting the same number of plants at random. The alleles present at six candidate gene loci were analysed before and after selection and correlated to WSC content. Significant differences in the allele frequency of L. perenne soluble-acid invertase1:4 were observed between the three populations with one haplotype significantly associated with the high WSC C2^S+ population (after three rounds of selection and two rounds of recombination). Moreover, WSC content was also associated with biomass accumulation. Thus, in addition to a 2.84-fold increase in WSC yield, the C2^S+ population also had 1.48-fold more biomass per plant, resulting in 3.9-fold higher WSC yield per plant than the control population.     

Ultra-Brief Intervention for Problem Drinkers: Results from a Randomized Controlled Trial

Background

There are a number of evidence-based, in-person clinical inteventions for problem drinkers, but most problem drinkers will never seek such treatments. Reaching the population of non-treatment seeking problem drinkers will require a different approach. Accordingly, this randomized clinical trial evaluated an intervention that has been validated in clinical settings and then modified into an ultra-brief format suitable for use as an indicated public health intervention (i.e., targeting the population of non-treatment seeking problem drinkers).

Methodology/Principal Findings

Problem drinkers (N = 1767) completed a baseline population telephone survey and then were randomized to one of three conditions – a personalized feedback pamphlet condition, a control pamphlet condition, or a no intervention control condition. In the week after the baseline survey, households in the two pamphlet conditions were sent their respective interventions by postal mail addressed to ‘Check Your Drinking.’ Changes in drinking were assessed post intervention at three-month and six-month follow-ups. The follow-up rate was 86% at three-months and 76% at six-months. There was a small effect (p = .04) in one of three outcome variables (reduction in AUDIT-C, a composite measure of quantity and frequency of drinking) observed for the personalized feedback pamphlet compared to the no intervention control. No significant differences (p>.05) between groups were observed for the other two outcome variables – number of drinks consumed in the past seven days and highest number of drinks on one occasion.

Conclusions/Significance

Based on the results of this study, we tentatively conclude that a brief intervention, modified to an ultra-brief, public health format can have a meaningful impact.

Trial Registration

ClinicalTrials.gov {"type":"clinical-trial","attrs":{"text":"NCT00688584","term_id":"NCT00688584"}}NCT00688584.     

IL-33, a potent inducer of adaptive immunity to intestinal nematodes

IL-33 (IL-1F11) binds ST2 (IL-1R4), both of which are associated with optimal CD4(+) Th2 polarization. Exogenous IL-33 drives induction of Th2-associated cytokines and associated pathological changes within the gut mucosa. Th2 polarization is also a prerequisite to expulsion of the intestinal-dwelling nematode Trichuris muris. In this study, we demonstrate that IL-33 mRNA is expressed early during parasite infection and susceptible mice can be induced to expel the parasite by a regime of exogenous IL-33 administration. IL-33 prevents an inappropriate parasite-specific Th1-polarized response and induces IL-4, IL-9, and IL-13. This redirection requires the presence of T cells and must occur at the initiation of the response to the pathogen. Interestingly, exogenous IL-33 also induced thymic stromal lymphopoietin mRNA within the infected caecum, an epithelial cell-restricted cytokine essential for the generation of Th2-driven parasite immunity. IL-33 also acts independently of T cells, altering intestinal pathology in chronically infected SCID mice, leading to an increased crypt length and intestinal epithelial cell proliferation, but reducing goblet cell hyperplasia. Thus, the ability of IL-33 to induce Th2 responses has functional relevance in the context of intestinal helminth infection, particularly during the initiation of the response.     

(D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues

The first enantioselective synthesis of (d)-2-tert-butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid 3 was achieved. The incorporation of the titled compound into growth hormone secretagogue (GHS) compounds resulted in new analogs 10 and 16, both of which had significantly increased in vitro potency. The compound 10 also showed improved in vivo efficacy as well as pharmacokinetic properties in rat models.